Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Pancreatic Neoplasms 2Neoplasm Metastasis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1High Risk Myeloid Malignancies 1Hematologic Diseases 1

Interventions

Specimen Handling 3Biopsy 3Azacitidine 2venetoclax 1veliparib 1ruxolitinib 1pevonedistat 1peginterferon alfa-2b 1onvansertib 1fludarabine phosphate 1axatilimab 1Whole-Body Irradiation 1Valganciclovir 1Transplantation Conditioning 1Topotecan 1Therapeutics 1Tacrolimus 1Sirolimus 1Positron-Emission Tomography 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Hyperbaric Oxygenation 1High-Energy Shock Waves 1Geriatric Assessment 1Ganciclovir 1Foscarnet 1Flow Cytometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative × Transplantation Conditioning × 1 year × Clear all
NCT04761770 2026-02-17

Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
33 enrolled
MyeloidOther hematologic neoplasm

Hematologic Diseases, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡